Bellevue Life Sciences Acquisition logo

Bellevue Life Sciences Acquisition

BLAC | NASDAQ
Chart Builder DCF Calculator
$3.01
-$3.72 (-55.27%)
At close: Feb 14, 2025, 04:00 PM ET
-55.27%

Rating

Updated: Sep 22, 2026
56
Fundamentals Strong
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $6.98M
1D Range
3.01 4.43
52W Range
3.01 13.40

Valuation (TTM)

PE 0.84
PB 0.06
EV/EBITDA -0.64

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target N/A
Loading financial charts...

Profile

Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, s...

Employees n/a
IPO Date Mar 21, 2023
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.